Cytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa-induced lung injury in mice.

Inhibition of the small GTPase RhoA attenuates the development of pulmonary edema and restores positive alveolar fluid clearance in a murine model of Pseudomonas aeruginosa pneumonia. Activated protein C (aPC) blocks the development of an unfavorably low ratio of small GTPase Rac1/RhoA activity in lung endothelium through endothelial protein C receptor (EPCR)/protease-activated receptor-1 (PAR-1)-dependent signaling mechanisms that include transactivating the sphingosine-1-phosphate (S1P) pathway. However, whether aPC's cytoprotective effects can attenuate the development of pulmonary edema and death associated with P. aeruginosa pneumonia in mice remains unknown. Thus, we determined whether the normalization of a depressed ratio of activated Rac1/RhoA by aPC would attenuate the P. aeruginosa-mediated increase in protein permeability across lung endothelial and alveolar epithelial barriers. Pretreatment with aPC significantly reduced P. aeruginosa-induced increases in paracellular permeability across pulmonary endothelial cell and alveolar epithelial monolayers via an inhibition of RhoA activation and a promotion of Rac1 activation that required the EPCR-PAR-1 and S1P pathways. Furthermore, pretreatment with aPC attenuated the development of pulmonary edema in a murine model of P. aeruginosa pneumonia. Finally, a cytoprotective-selective aPC mutant, aPC-5A, which lacks most of aPC's anticoagulant activity, reproduced the protective effect of wild-type aPC by attenuating the development of pulmonary edema and decreasing mortality in a murine model of P. aeruginosa pneumonia. Taken together, these results demonstrate a critical role for the cytoprotective activities of aPC in attenuating P. aeruginosa-induced lung vascular permeability and mortality, suggesting that cytoprotective-selective aPC-5A with diminished bleeding risks could attenuate the lung damage caused by P. aeruginosa in critically ill patients.

[1]  J. Pittet,et al.  Critical Role of the Small GTPase RhoA in the Development of Pulmonary Edema Induced by Pseudomonas aeruginosa in Mice , 2010, Anesthesiology.

[2]  Xiaoguang Sun,et al.  Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung. , 2010, American journal of respiratory cell and molecular biology.

[3]  N. Maniatis,et al.  Inhaled activated protein C protects mice from ventilator-induced lung injury , 2010, Critical care.

[4]  A. Malik,et al.  Regulation of endothelial permeability via paracellular and transcellular transport pathways. , 2010, Annual review of physiology.

[5]  Richard Bonneau,et al.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome , 2010, Proceedings of the National Academy of Sciences.

[6]  K. Shokat,et al.  Transforming Growth Factor β1 Inhibits Cystic Fibrosis Transmembrane Conductance Regulator-dependent cAMP-stimulated Alveolar Epithelial Fluid Transport via a Phosphatidylinositol 3-Kinase-dependent Mechanism* , 2009, The Journal of Biological Chemistry.

[7]  S. Keshavjee,et al.  Activated protein C in ischemia-reperfusion injury after experimental lung transplantation. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  M. Matthay,et al.  Protective mechanisms of activated protein C in severe inflammatory disorders , 2009, British journal of pharmacology.

[9]  José A Fernández,et al.  Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant. , 2009, Blood.

[10]  C. Cheadle,et al.  Activated protein C protects against ventilator-induced pulmonary capillary leak. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[11]  J. Trejo,et al.  Caveolae are required for protease-selective signaling by protease-activated receptor–1 , 2009, Proceedings of the National Academy of Sciences.

[12]  P. Weinreb,et al.  Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). , 2009, The American journal of pathology.

[13]  Hiroshi Deguchi,et al.  Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells , 2009, Proceedings of the National Academy of Sciences.

[14]  M. Matthay,et al.  Role of coagulation pathways and treatment with activated protein C in hyperoxic lung injury , 2008, Thorax.

[15]  M. Siegel,et al.  Randomized clinical trial of activated protein C for the treatment of acute lung injury. , 2008, American journal of respiratory and critical care medicine.

[16]  P. Weinreb,et al.  Interleukin-1&bgr; Causes Acute Lung Injury via &agr;v&bgr;5 and &agr;v&bgr;6 Integrin–Dependent Mechanisms , 2008, Circulation research.

[17]  J. Chun,et al.  Dendritic cell PAR1–S1P3 signalling couples coagulation and inflammation , 2008, Nature.

[18]  J. Griffin,et al.  Activated Protein C Mutant with Minimal Anticoagulant Activity, Normal Cytoprotective Activity, and Preservation of Thrombin Activable Fibrinolysis Inhibitor-dependent Cytoprotective Functions* , 2007, Journal of Biological Chemistry.

[19]  Nigel Mackman,et al.  Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein C , 2007, The Journal of experimental medicine.

[20]  N. Costes,et al.  Effect of activated protein C on pulmonary blood flow and cytokine production in experimental acute lung injury , 2007, Intensive Care Medicine.

[21]  T. van der Poll,et al.  Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in rats , 2007, Critical care medicine.

[22]  M. Matthay,et al.  Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. , 2007, American journal of respiratory cell and molecular biology.

[23]  D. Sheppard,et al.  Integrin αvβ5 Regulates Lung Vascular Permeability and Pulmonary Endothelial Barrier Function , 2007 .

[24]  D. Glidden,et al.  Increased Plasminogen Activator Inhibitor-1 Concentrations in Bronchoalveolar Lavage Fluids Are Associated with Increased Mortality in a Cohort of Patients with Pseudomonas aeruginosa , 2007, Anesthesiology.

[25]  J. Rello,et al.  Risk Factors for Ventilator-associated Pneumonia by Pseudomonas aeruginosa in Presence of Recent Antibiotic Exposure , 2006, Anesthesiology.

[26]  J. Fraser,et al.  Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis , 2006, Critical care medicine.

[27]  P. Parsons,et al.  Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome* , 2006, Critical care medicine.

[28]  R. Chambers,et al.  Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. , 2006, The Journal of clinical investigation.

[29]  R. Neviere,et al.  Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response , 2006, Respiratory research.

[30]  T. van der Poll,et al.  Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans. , 2005, American journal of respiratory and critical care medicine.

[31]  J. Garcia,et al.  Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement , 2005, Journal of Biological Chemistry.

[32]  C. Feistritzer,et al.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. , 2005, Blood.

[33]  J. Rello,et al.  Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. , 2002, Critical care medicine.

[34]  R. Savel,et al.  Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. , 2001, The Journal of infectious diseases.

[35]  Naftali Kaminski,et al.  TGF-β is a critical mediator of acute lung injury , 2001 .

[36]  C. Ruppert,et al.  Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. , 2000, American journal of respiratory and critical care medicine.

[37]  M. Rué,et al.  Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. , 1997, Critical care medicine.

[38]  A. Chang,et al.  Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. , 1987, The Journal of clinical investigation.

[39]  C. Deutschman,et al.  Role of small GTPases and alphavbeta5 integrin in Pseudomonas aeruginosa-induced increase in lung endothelial permeability. , 2009, American journal of respiratory cell and molecular biology.

[40]  J. Griffin,et al.  bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. The cytoprotective protein C pathway , 2006 .